Mastocytosis News and Research

RSS
Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

People with venom allergies are more likely to have bone marrow disorder

People with venom allergies are more likely to have bone marrow disorder

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

Researchers detect a novel cause of acquired lipodystrophy

Researchers detect a novel cause of acquired lipodystrophy

Leukemia is not just one disease

Leukemia is not just one disease

Researchers map genetic mutation behind incurable disease

Researchers map genetic mutation behind incurable disease

Researchers design new combination therapy for reducing NSCLC cell growth

Researchers design new combination therapy for reducing NSCLC cell growth

Inexplicable cases of anaphylaxis caused by uncommon red meat allergy, study finds

Inexplicable cases of anaphylaxis caused by uncommon red meat allergy, study finds

Study provides new insight into development of immune cells

Study provides new insight into development of immune cells

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

New drug holds potential for treating advanced mastocytosis

New drug holds potential for treating advanced mastocytosis

New funding for Centenary's life saving research

New funding for Centenary's life saving research

New cell type appears to drive life-threatening food allergies

New cell type appears to drive life-threatening food allergies

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

Overview of Blueprint Medicines' kinase drug discovery strategy published in JCI

Overview of Blueprint Medicines' kinase drug discovery strategy published in JCI

Novartis to highlight advances in blood, breast cancer research at ASH and SABCS 2014

Novartis to highlight advances in blood, breast cancer research at ASH and SABCS 2014

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Complex process of bone disease evident in mastocytosis

Complex process of bone disease evident in mastocytosis

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting